{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Diphtheria+and+Tetanus+Toxoids+Adsorbed&page=2", "query": { "intervention": "Diphtheria and Tetanus Toxoids Adsorbed", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 41, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Diphtheria+and+Tetanus+Toxoids+Adsorbed&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Diphtheria+and+Tetanus+Toxoids+Adsorbed&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-10T20:14:24.016Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01049035", "title": "A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningitis", "Meningococcal Infection" ], "interventions": [ { "name": "Quadrivalent Meningococcal Polysaccharide (A, C, Y, and W-135) Tetanus Protein Conjugate", "type": "BIOLOGICAL" }, { "name": "Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus B Conjugate (Tetanus Toxoid Conjugate) Vaccine Combined (DTaP-IPV/Hib combined)", "type": "BIOLOGICAL" }, { "name": "M-M-RII-Measles, Mumps, and Rubella Virus Vaccine Live", "type": "BIOLOGICAL" }, { "name": "Varicella Virus Vaccine Live", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)", "type": "BIOLOGICAL" }, { "name": "Rotavirus Vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis B Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "365 Days", "sex": "ALL", "summary": "42 Days to 365 Days" }, "enrollment_count": 580, "start_date": "2009-12-16", "completion_date": "2012-02-13", "has_results": true, "last_update_posted_date": "2022-03-28", "last_synced_at": "2026-10-10T20:14:24.016Z", "location_count": 25, "location_summary": "Birmingham, Alabama • Tuscaloosa, Alabama • Jonesboro, Arkansas + 20 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01049035" }, { "nct_id": "NCT03620162", "title": "A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Infections" ], "interventions": [ { "name": "Prevnar 13™", "type": "BIOLOGICAL" }, { "name": "V114", "type": "BIOLOGICAL" }, { "name": "RotaTeq™", "type": "BIOLOGICAL" }, { "name": "Pentacel™", "type": "BIOLOGICAL" }, { "name": "RECOMBIVAX HB™", "type": "BIOLOGICAL" }, { "name": "HIBERIX™", "type": "BIOLOGICAL" }, { "name": "M-M-R™ II", "type": "BIOLOGICAL" }, { "name": "VARIVAX™", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "90 Days", "sex": "ALL", "summary": "42 Days to 90 Days" }, "enrollment_count": 900, "start_date": "2018-10-18", "completion_date": "2020-12-14", "has_results": true, "last_update_posted_date": "2023-01-17", "last_synced_at": "2026-10-10T20:14:24.016Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Jonesboro, Arkansas + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03620162" }, { "nct_id": "NCT00662870", "title": "Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diphtheria", "Tetanus", "Whooping Cough", "Polio", "Haemophilus Influenzae Type b" ], "interventions": [ { "name": "DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine)", "type": "BIOLOGICAL" }, { "name": "Pentacel: DTaP-IPV/Hib", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "84 Days", "sex": "ALL", "summary": "42 Days to 84 Days" }, "enrollment_count": 1941, "start_date": "2001-05", "completion_date": "2004-01", "has_results": false, "last_update_posted_date": "2012-01-31", "last_synced_at": "2026-10-10T20:14:24.016Z", "location_count": 26, "location_summary": "Fayetteville, AR 72703, Arkansas • Jonesboro, AR 72401, Arkansas • Little Rock, AR 72211, Arkansas + 23 more", "locations": [ { "city": "Fayetteville, AR 72703", "state": "Arkansas" }, { "city": "Jonesboro, AR 72401", "state": "Arkansas" }, { "city": "Little Rock, AR 72211", "state": "Arkansas" }, { "city": "Fountain Valley, CA 92708", "state": "California" }, { "city": "Englewood, CO 80112", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00662870" }, { "nct_id": "NCT03299309", "title": "PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Recurrent Medulloblastoma", "Recurrent Brain Tumor, Childhood", "Malignant Glioma" ], "interventions": [ { "name": "PEP-CMV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daniel Landi", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "3 Years to 35 Years" }, "enrollment_count": 30, "start_date": "2018-06-29", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-06-18", "last_synced_at": "2026-10-10T20:14:24.016Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03299309" }, { "nct_id": "NCT01659996", "title": "Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Meningitis", "Meningococcal Infection", "Diphtheria", "Tetanus", "Pertussis", "Haemophilus Influenzae Serotype b (Hib)" ], "interventions": [ { "name": "Meningococcal polysaccharide diphtheria toxoid conjugate", "type": "BIOLOGICAL" }, { "name": "Meningococcal polysaccharide diphtheria toxoid conjugate + Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed", "type": "BIOLOGICAL" }, { "name": "Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "9 Months", "maximum_age": "18 Months", "sex": "ALL", "summary": "9 Months to 18 Months" }, "enrollment_count": 1394, "start_date": "2012-07", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2015-12-15", "last_synced_at": "2026-10-10T20:14:24.016Z", "location_count": 56, "location_summary": "Birmingham, Alabama • Pinson, Alabama • Tucson, Arizona + 50 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Pinson", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01659996" }, { "nct_id": "NCT00457249", "title": "A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pertussis", "Tetanus", "Diphtheria" ], "interventions": [ { "name": "ADACEL®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed", "type": "BIOLOGICAL" }, { "name": "DECAVAC®: Tetanus and Diphtheria Toxoids Adsorbed", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 1564, "start_date": "2007-03", "completion_date": "2008-11", "has_results": true, "last_update_posted_date": "2012-10-19", "last_synced_at": "2026-10-10T20:14:24.016Z", "location_count": 19, "location_summary": "Chandler, Arizona • Phoenix, Arizona • Cypress, California + 15 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Cypress", "state": "California" }, { "city": "San Luis Obispo", "state": "California" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00457249" }, { "nct_id": "NCT00707148", "title": "Pertussis Vaccine in Healthy Pregnant Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diphtheria", "Pertussis", "Tetanus" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "45 Years", "sex": "ALL", "summary": "Up to 45 Years" }, "enrollment_count": 80, "start_date": "2009-01", "completion_date": "2012-05", "has_results": false, "last_update_posted_date": "2014-07-25", "last_synced_at": "2026-10-10T20:14:24.016Z", "location_count": 4, "location_summary": "Durham, North Carolina • Houston, Texas • Seattle, Washington", "locations": [ { "city": "Durham", "state": "North Carolina" }, { "city": "Houston", "state": "Texas" }, { "city": "Seattle", "state": "Washington" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00707148" }, { "nct_id": "NCT00319553", "title": "Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pertussis", "Tetanus", "Diphtheria" ], "interventions": [ { "name": "ADACEL®:Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed", "type": "BIOLOGICAL" }, { "name": "BOOSTRIX®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "11 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "11 Years to 18 Years" }, "enrollment_count": 647, "start_date": "2006-05", "completion_date": "2008-12", "has_results": true, "last_update_posted_date": "2012-10-05", "last_synced_at": "2026-10-10T20:14:24.016Z", "location_count": 10, "location_summary": "Annapolis, Maryland • Baltimore, Maryland • Frederick, Maryland + 6 more", "locations": [ { "city": "Annapolis", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Frederick", "state": "Maryland" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00319553" }, { "nct_id": "NCT00474526", "title": "A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningitis, Meningococcal" ], "interventions": [ { "name": "Meningococcal ACWY Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "DTaP-IPV-HBV", "type": "BIOLOGICAL" }, { "name": "Hib", "type": "BIOLOGICAL" }, { "name": "Rotavirus", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 7-valent Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "HAV", "type": "BIOLOGICAL" }, { "name": "MMR-V", "type": "BIOLOGICAL" }, { "name": "DTaP", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Vaccines", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Months", "maximum_age": "2 Months", "sex": "ALL", "summary": "2 Months to 2 Months" }, "enrollment_count": 4545, "start_date": "2007-03", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2014-03-24", "last_synced_at": "2026-10-10T20:14:24.016Z", "location_count": 53, "location_summary": "Bessemer, Alabama • Birmingham, Alabama • Downey, California + 43 more", "locations": [ { "city": "Bessemer", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Downey", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00474526" }, { "nct_id": "NCT00385255", "title": "Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acellular Pertussis", "Diphtheria", "Tetanus" ], "interventions": [ { "name": "Fluarix®", "type": "BIOLOGICAL" }, { "name": "Boostrix®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 1726, "start_date": "2006-10-23", "completion_date": "2007-02-28", "has_results": true, "last_update_posted_date": "2019-06-10", "last_synced_at": "2026-10-10T20:14:24.016Z", "location_count": 12, "location_summary": "Huntsville, Alabama • Chandler, Arizona • Mesa, Arizona + 8 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Inverness", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00385255" } ] }